Twist Bioscience Corporation (TWST) Tops Q2 EPS by 2c ; Offers Guidance

Twist Bioscience Corporation (NASDAQ: TWST) reported Q2 EPS of ($0.79), $0.02 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $75.3 million versus the consensus estimate of $70.7 million.

GUIDANCE:

Twist Bioscience Corporation sees FY2024 revenue of $300-304 million, versus the consensus of $293.1 million.

Twist Bioscience Corporation sees Q3 2024 revenue of ~$77 million, versus the consensus of $77.34 million.

Twist Bioscience Corporation sees Q4 2024 revenue of $77-80 million, versus the consensus of $83.6 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance